Synthesis and Anticonvulsant Activity Evaluation of 7-Alkoxy[1,2,4]triazolo[3,4-b]benzothiazol-3(2h)-ones.

Da-Chuan Liu,Xian-Qing Deng,Shi-Ben Wang,Zhe-Shan Quan
DOI: https://doi.org/10.1002/ardp.201300277
2014-01-01
Archiv der Pharmazie
Abstract:A new series of 7‐alkoxy[1,2,4]triazolo[3,4‐b]benzothiazol‐3(2H)‐ones were synthesized and evaluated for their anticonvulsant activities. Among these compounds, 7‐propoxy[1,2,4]triazolo[3,4‐b]benzothiazol‐3(2H)‐one (4c) and 7‐butoxy[1,2,4]triazolo[3,4‐b]benzothiazol‐3(2H)‐one (4d) showed the highest activity against maximal electroshock (MES)‐induced tonic extension [effective dose (ED)50: 11.4 and 13.6 mg/kg, respectively]. It is worth mentioning that compound 4d showed especially low neurotoxicity, which led to a high protective index (PI >51). The orally anticonvulsant activity data of compound 4d further confirmed its efficacy, in an MES test, and its high safety with a PI value of 50.2. In addition, the potency of compound 4h against seizures induced by pentylenetetrazole, 3‐mercaptopropionic acid, and bicuculline in the chemical‐induced seizure tests suggested that compound 4d may exert its anticonvulsant activity through affecting the GABAergic system.
What problem does this paper attempt to address?